The global nootropics market share in 2026 is witnessing substantial growth driven by increasing consumer awareness regarding cognitive health, memory enhancement, and mental performance optimization. According to Fortune Business Insights, the global nootropics market size was valued at USD 6.02 billion in 2025 and is projected to grow from USD 6.65 billion in 2026 to USD 14.79 billion by 2034, exhibiting a CAGR of 10.50% during the forecast period.
Nootropics, also known as “smart drugs” or cognitive enhancers, are gaining popularity among students, working professionals, and aging populations. These supplements and compounds help improve brain function, including memory, creativity, focus, and motivation. Rising demand for mental clarity and productivity is significantly contributing to market expansion.
The increasing prevalence of neurological disorders, stress-related conditions, and cognitive decline among the global population is fueling demand for nootropic products. Additionally, lifestyle changes, rising competition in academic and professional environments, and the growing inclination toward self-improvement are further boosting adoption.
The market is also supported by the growing trend of preventive healthcare and the increasing use of dietary supplements. Consumers are actively seeking natural and plant-based nootropics that offer minimal side effects, further shaping product innovation and development.
Drivers: